OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer
Xiaowei Chen, Guangyu Bai, Ruochuan Zang, et al.
Translational Oncology (2023) Vol. 35, pp. 101725-101725
Open Access | Times Cited: 6
Xiaowei Chen, Guangyu Bai, Ruochuan Zang, et al.
Translational Oncology (2023) Vol. 35, pp. 101725-101725
Open Access | Times Cited: 6
Showing 6 citing articles:
Molecular imaging research on 18F-FDG PET/CT and biomarker analysis predicts the pathological response to neoadjuvant camrelizumab combined with chemotherapy for resectable stage IIIA-IIIB NSCLC.
Kaiyue Wang, Xiaohan Wang, Xue Meng, et al.
Research Square (Research Square) (2025)
Closed Access
Kaiyue Wang, Xiaohan Wang, Xue Meng, et al.
Research Square (Research Square) (2025)
Closed Access
Diagnostic Meta-Analysis of 18F-FDG PET/CT Metabolic Parameters for Early Prediction of Pathological Response in NSCLCTreated with Neoadjuvant Immuno(chemo)Therapy
Hongsheng Deng, Zichen Deng, Yi Zhao, et al.
(2025)
Closed Access
Hongsheng Deng, Zichen Deng, Yi Zhao, et al.
(2025)
Closed Access
Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review
Kyoichi Kaira, Yoshinobu Ichiki, Hisao Imai, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 5, pp. 1137-1149
Open Access | Times Cited: 2
Kyoichi Kaira, Yoshinobu Ichiki, Hisao Imai, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 5, pp. 1137-1149
Open Access | Times Cited: 2
[18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
Yinjun Dong, Zhendan Wang, Xinying Hu, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268557-jnumed.124.268557
Closed Access | Times Cited: 2
Yinjun Dong, Zhendan Wang, Xinying Hu, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268557-jnumed.124.268557
Closed Access | Times Cited: 2
Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma
Ye Wang, Yingqiu Song, Runze Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Ye Wang, Yingqiu Song, Runze Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy
Min Zhang, Liang Zhu, Sibei Liang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Min Zhang, Liang Zhu, Sibei Liang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
